{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:19:20Z","timestamp":1791292760880,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011033","name":"Thermo Fisher Scientific","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011033","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5T32GM066691"],"award-info":[{"award-number":["5T32GM066691"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.clinbiochem.2015.05.023","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T10:02:52Z","timestamp":1435312972000},"page":"1283-1290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["The development of a high-performance liquid chromatography\u2013tandem mass spectrometric method for simultaneous quantification of morphine, morphine-3-\u03b2-glucuronide, morphine-6-\u03b2-glucuronide, hydromorphone, and normorphine in serum"],"prefix":"10.1016","volume":"48","author":[{"given":"David","family":"Sartori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamorah","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn","family":"Breaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0005","first-page":"258","article-title":"Morphine metabolites: clinical implications","volume":"21","author":"Skarke","year":"2002"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0010","series-title":"DHHS Publication No. SMA 07-4293. Series H-32","article-title":"Results from the 2006 National Survey on Drug Use and Health: National Findings","year":"2007"},{"issue":"18","key":"10.1016\/j.clinbiochem.2015.05.023_bb0015","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.2012.3951","article-title":"Neonatal abstinence syndrome and associated health care expenditures: United States, 2000\u20132009","volume":"307","author":"Patrick","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jpeds.2014.05.010","article-title":"Current Management of neonatal abstinence syndrome secondary to intrauterine opioid exposure","volume":"165","author":"Wiles","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0025","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ogc.2014.02.010","article-title":"Neonatal opioid withdrawal syndrome","volume":"41","author":"Sutter","year":"2014","journal-title":"Obstet Gynecol Clin N Am"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0030","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/jp.2014.114","article-title":"Variation in treatment of neonatal abstinence syndrome in US Children's Hospitals, 2004\u20132011","volume":"34","author":"Patrick","year":"2014","journal-title":"J Perinatol"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0021-9673(95)01090-4","article-title":"Determination of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human serum by solid-phase extraction and liquid chromatography\u2013mass spectrometry with electrospray ionization","volume":"729","author":"Treyfors","year":"1996","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0040","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jssc.200900117","article-title":"Simultaneous analysis of morphine-related compounds in plasma using mixed-mode solid phase extraction and ultra performance liquid chromatography\u2013mass spectrometry","volume":"32","author":"Fountain","year":"2009","journal-title":"J Sep Sci"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00216-011-4775-z","article-title":"A sensitive assay for the quantification of morphine and its active metabolites in human plasma and dried blood spots using high-performance liquid chromatography\u2013tandem mass spectrometry","volume":"400","author":"Clavijo","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0050","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/FTD.0b013e318283e29a","article-title":"Therapeutic monitoring of opioids: a sensitive LC\u2013MS\/MS method for quantitation of several opioids including hydrocodone and its metabolites","volume":"35","author":"Langman","year":"2013","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0055","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/jat\/bks063","article-title":"Improved detection of opioid use in chronic pain patients through monitoring of opioid glucuronides in urine","volume":"36","author":"Dickerson","year":"2012","journal-title":"J Anal Tox"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0060","series-title":"CLSI document C62-A","article-title":"Liquid chromatography\u2013mass spectrometry methods; approved guidelines","author":"CLSI","year":"2014"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0065","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC\u2013MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0070","series-title":"CLSI Document EP10-A3-AMD","article-title":"Preliminary evaluation of quantitative clinical laboratory methods; approved guideline \u2014 third edition","author":"CLSI","year":"2014"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0075","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jat\/31.7.394","article-title":"Method for quantification of opioids and their metabolites in autopsy blood by liquid chromatography\u2013tandem mass spectrometry","volume":"31","author":"Al-Asmari","year":"2007","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.forsciint.2009.02.011","article-title":"A validated hybrid quadrupole linear ion-trap LC\u2013MS method for the analysis of morphine and morphine glucuronides applied to opiate deaths","volume":"187","author":"Taylor","year":"2009","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/bja\/aeh042","article-title":"Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children","volume":"92","author":"Bouwmeester","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0090","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bdd.649","article-title":"Pharmacokinetic and pharmacodynamic study of morphine and morphine 6-glucuronide after oral and intravenous administration of morphine in children with cancer","volume":"30","author":"Mashayekhi","year":"2009","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0095","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4155\/bio.13.109","article-title":"Severe impact of hemolysis on stability of phenolic compounds","volume":"5","author":"B\u00e9rub\u00e9","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/30.1.1","article-title":"Evidence of morphine metabolism to hydromorphone in pain patients chronically treated with morphine","volume":"30","author":"Cone","year":"2006","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0105","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1526-4637.2007.00354.x","article-title":"Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine","volume":"9","author":"Wasan","year":"2008","journal-title":"Pain Med"},{"key":"10.1016\/j.clinbiochem.2015.05.023_bb0110","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1556-4029.2008.00730.x","article-title":"The detection of hydromorphone in urine specimens with high morphine concentrations","volume":"53","author":"McDonough","year":"2008","journal-title":"J Forensic Sci"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015002520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015002520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:47:34Z","timestamp":1757864854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015002520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":22,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0009912015002520"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.05.023","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of a high-performance liquid chromatography\u2013tandem mass spectrometric method for simultaneous quantification of morphine, morphine-3-\u03b2-glucuronide, morphine-6-\u03b2-glucuronide, hydromorphone, and normorphine in serum","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.05.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}